The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials
HS Code: 2934999099
SECTION 6
PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
CHAPTER 29
Organic chemicals
HEADING 2934
Nucleic acids and their salts; whether or not chemically defined; Other heteroeyclic compounds;
HS Code Structure Breakdown
| Level | Code | Description |
|---|---|---|
| Section | 6 | PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES |
| Chapter | 29 | Organic chemicals |
| Heading | 2934 | Nucleic acids and their salts; whether or not chemically defined; Other heteroeyclic compounds; |
| Subheading | 293499 | The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials |
| Commodity | 2934999099 | The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials |
HS Code 2934999099 for The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials
Product Wiki
The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.
Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials, with its export volume maintaining a high level over the long term.
Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials.
With technological advancements and the diversification of market demands, the scope of application for The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials continues to expand, driving the development of related industries.
Currently, the global supply-demand balance of The taxation number of other heterocyclic compounds produced by the separation of anti-cancer drug raw materials is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.
Partner



Our licenses

China

HK MSO License

Singapore

UK API License

Netherlands

US MSB

CA MSB

AU RSP

